The first gene therapy was approved by the FDA in 2017. But it took three years for CMS to approve a payment structure for hospitals that enabled Medicare patients to access the breakthrough treatment.
To ensure the ongoing affordability of generic medications for Americans, BCBS is committing $55 million to establish a partnership with Civica Rx to reduce costs of generics for consumers.
Prescription drug overpayments occur when commercially insured patients’ copayments exceed the total cost of the drug to their insurer or pharmacy benefit manager.
Panel discussion of the role of the U.S. government in price negotiations.